The controversial Theranos blood-testing company closed its last laboratory after failing another U.S. inspection.
US federal regulators from the Centers for Medicare and Medicaid Services blasted blood testing start-up Theranos for lab deficiencies and demanded corrective action within 10 days.
Blood-testing unicorn company Theranos is currently in hot water as US health inspectors discovered a number of undisclosed deficiencies in its Newark-based blood-testing facility.
The USDA has revised poultry plant inspections for the first time in over 50 years.
Researchers found that 43 percent of patients do not get an inspection for their lower back pain.